203
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin

, , , , , , & show all
Pages 349-357 | Received 06 Aug 2004, Accepted 02 Nov 2004, Published online: 09 Jul 2009

References

  • Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 2003;55:992–9.
  • Ersek M, Ferrell BR, Dow KH, Melancon CH. Quality of life in women with ovarian cancer. West J Nurs Res 1997;19:334–50.
  • Miller BE, Pittman B, Case D, McQuellon RP. Quality of life after treatment for gynecologic malignancies: A pilot study in an outpatient clinic. Gynecol Oncol 2002;87:178–84.
  • Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA, Wolf JK, de Moor C, Garshenson, DM. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 2000;78:302–8.
  • Pignata S, Ballatori E, Favalli G, Scambia G. Quality of life: Gynaecological cancers. Ann Oncol 2001; 12(Suppl 3):S37–42.
  • Ferrell B, Ervin K, Smith S, Marek T, Melancon C. Family perspectives of ovarian cancer. Cancer Pract 2002;10:269–76.
  • Ozols RF. The current role of gemcitabine in ovarian cancer. Semin Oncol 2001;28(2 Suppl 7):18–24.
  • Gordon AN, Fleagle JT, Guthrie D, Parkin DE, Gore ME, Lacave AJ. Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Chin Oncol 2001;19: 3312–22.
  • Muggia FM, Hainsworth JD, Jeffers S, Miller P, Groshen S, Tan M, Roman L, Uziely B, Muderspach L, Garcia A, Burnett A, Greco FA, Morrow CP, Paradiso LJ, Liang U. Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation. J Chin Oncol 1997;15:987–93.
  • Huang SK, Stauffer PR, Hong K, Guo JW, Phillips TL, Huang A, Papahadjopoulos, D. Liposomes and hyperthermia in mice: Increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 1994;54:2186–91.
  • Ohue M, Takahashi K, Yamaguchi T, Tsujie M, Mori T. [Clinical trial of thermoradiotherapy and internal iliac arterial infusion of 5-FU for unresectable pelvic tumor]. Gan To Kagaku Ryoho 2001;28: 1612–5.
  • Tohnai I, Hayashi Y, Mitsudo K, Kobayashi T, Matsui M, Ueda M. Thermochemotherapy for cancer of the tongue using magnetic induction hyperthermia (implant heating system: IHS). Nagoya J Med Sci 1996;59:49–54.
  • McQuellon RP, Loggie BW, Fleming RA, Russell GB, Lehman AB, Rambo TD. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 2001;27:65–73.
  • Lakusta CM, Atkinson MJ, Robinson JW, Nation J, Taenzer PA, Campo MG. Quality of life in ovarian cancer patients receiving chemotherapy. Gynecol Oncol 2001;81:490–5.
  • Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002;95:155–63.
  • Klee MC, King MT, Machin D, Hansen HH. A clinical model for quality of life assessment in cancer patients receiving chemotherapy. Ann Oncol 2000;11:23–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.